Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Pharma
Boryung picks up Taxotere rights in deal worth up to $205M
Boryung is boosting its global oncology foothold with a deal to take on Sanofi’s time-honored chemotherapy Taxotere (docetaxel) in nearly 20 markets.
Zoey Becker
Sep 30, 2025 11:56am
Sanofi expands price cut to $35 monthly for all insulin products
Sep 26, 2025 1:00pm
AZ's Fasenra flunks COPD trial as Saphnelo makes grade in lupus
Sep 17, 2025 11:47am
PE firm strikes €4.1B deal for Czech generics maker Zentiva: FT
Sep 11, 2025 10:25am
Sanofi wins big at the 2025 Fierce Pharma Marketing Awards
Sep 11, 2025 8:32am
Relatability, authenticity key to reaching patients, experts say
Sep 10, 2025 2:15pm
